Methylene Blue Does Not Have to Be Considered Only as Rescue Therapy for Distributive Shock

Journal of Medical Toxicology

Volumn 9, Issue 4, 2013, Pages 426-

  Evora, Paulo Roberto Barbosa ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC GMP; GUANYLATE CYCLASE; METHYLENE BLUE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NORADRENALIN;

ANAPHYLAXIS; CONTINUOUS INFUSION; DISTRIBUTIVE SHOCK; HUMAN; HYPOTENSION; LETTER; METABOLIC ACIDOSIS; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; RECOMMENDED DRUG DOSE; SEPTIC SHOCK; VASOCONSTRICTION;

ANIMALS; ANTIDOTES; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; HUMANS; METHYLENE BLUE; MODELS, BIOLOGICAL; SECOND MESSENGER SYSTEMS; SHOCK;

EID: 84889243287     PISSN: 15569039     EISSN: 19376995     Source Type: Journal    
DOI: 10.1007/s13181-013-0333-8     Document Type: Letter

References (5)

1. Jang DH, Nelson LS, Hoffman RS (2013) Methylene blue for distributive shock: a potential new use of an old antidote j med toxicol. In press.
2. Evora PR, Ribeiro PJ, Vicente WV et al (2009) Methylene blue for vasoplegic syndrome treatment in heart surgery: fifteen years of questions, answers, doubts and certainties. Rev Bras Cir Cardiovasc 24(3): 279-288.
3. Blacker SN, Whalen FX (2013) Vasoplegic syndrome: does the timing of methylene blue matter? J Anesthe Clinic Res 4: 333.
4. Fernandes D, da Silva-Santos JE, Duma D et al (2006) Nitric oxide-dependent reduction in soluble guanylate cyclase functionality accounts for early lipopolysaccharide-induced changes in vascular reactivity. Mol Pharmacol 69(3): 983-990.
5. Viaro F, Baldo CF, Capellini VK et al (2008) Plasma nitrate/nitrite (NOx) is not a useful biomarker to predict inherent cardiopulmonary bypass inflammatory response. J Card Surg 23(4): 336-338.